545 related articles for article (PubMed ID: 33815371)
1. Why Inhibition of IL-23 Lacked Efficacy in Ankylosing Spondylitis.
McGonagle D; Watad A; Sharif K; Bridgewood C
Front Immunol; 2021; 12():614255. PubMed ID: 33815371
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-23 pathway at the enthesis: The emerging story of enthesitis in spondyloarthropathy.
Bridgewood C; Sharif K; Sherlock J; Watad A; McGonagle D
Immunol Rev; 2020 Mar; 294(1):27-47. PubMed ID: 31957051
[TBL] [Abstract][Full Text] [Related]
3. Inflammatory pathways in spondyloarthritis.
Hreggvidsdottir HS; Noordenbos T; Baeten DL
Mol Immunol; 2014 Jan; 57(1):28-37. PubMed ID: 23969080
[TBL] [Abstract][Full Text] [Related]
4. The Role of the IL-23/IL-17 Pathway in the Pathogenesis of Spondyloarthritis.
Tsukazaki H; Kaito T
Int J Mol Sci; 2020 Sep; 21(17):. PubMed ID: 32899140
[TBL] [Abstract][Full Text] [Related]
5. The IL-17/IL-23 Axis and Its Genetic Contribution to Psoriatic Arthritis.
Vecellio M; Hake VX; Davidson C; Carena MC; Wordsworth BP; Selmi C
Front Immunol; 2020; 11():596086. PubMed ID: 33574815
[TBL] [Abstract][Full Text] [Related]
6. The interleukin-23/interleukin-17 immune axis as a promising new target in the treatment of spondyloarthritis.
Yeremenko N; Paramarta JE; Baeten D
Curr Opin Rheumatol; 2014 Jul; 26(4):361-70. PubMed ID: 24827753
[TBL] [Abstract][Full Text] [Related]
7. IL-23 and axial disease: do they come together?
Mease P; van den Bosch F
Rheumatology (Oxford); 2021 Oct; 60(Suppl 4):iv28-iv33. PubMed ID: 34668015
[TBL] [Abstract][Full Text] [Related]
8. Clinical Trials Supporting the Role of the IL-17/IL-23 Axis in Axial Spondyloarthritis.
Ceribelli A; Motta F; Vecellio M; Isailovic N; Ciccia F; Selmi C
Front Immunol; 2021; 12():622770. PubMed ID: 34149686
[TBL] [Abstract][Full Text] [Related]
9. [Spondyloarthritis].
Syrbe U; Baraliakos X
Z Rheumatol; 2018 Nov; 77(9):783-788. PubMed ID: 29767341
[TBL] [Abstract][Full Text] [Related]
10. The IL-23/IL-17A axis in spondyloarthritis: therapeutics informing pathogenesis?
Siebert S; McGucken A; McInnes IB
Curr Opin Rheumatol; 2020 Jul; 32(4):349-356. PubMed ID: 32412997
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-23 mediates the intestinal response to microbial β-1,3-glucan and the development of spondyloarthritis pathology in SKG mice.
Benham H; Rehaume LM; Hasnain SZ; Velasco J; Baillet AC; Ruutu M; Kikly K; Wang R; Tseng HW; Thomas GP; Brown MA; Strutton G; McGuckin MA; Thomas R
Arthritis Rheumatol; 2014 Jul; 66(7):1755-67. PubMed ID: 24664521
[TBL] [Abstract][Full Text] [Related]
12. Secukinumab: a promising therapeutic option in spondyloarthritis.
Maldonado-Ficco H; Perez-Alamino R; Maldonado-Cocco JA
Clin Rheumatol; 2016 Sep; 35(9):2151-61. PubMed ID: 27437696
[TBL] [Abstract][Full Text] [Related]
13. From the Genetics of Ankylosing Spondylitis to New Biology and Drug Target Discovery.
Nancy Z; Yan L; Hui S; Paul B; Liye C
Front Immunol; 2021; 12():624632. PubMed ID: 33679768
[TBL] [Abstract][Full Text] [Related]
14. IL-23 Inhibition in Ankylosing Spondylitis: Where Did It Go Wrong?
Baeten D; Adamopoulos IE
Front Immunol; 2020; 11():623874. PubMed ID: 33679714
[TBL] [Abstract][Full Text] [Related]
15. ILC3 in Axial Spondyloarthritis: the Gut Angle.
Mauro D; Macaluso F; Fasano S; Alessandro R; Ciccia F
Curr Rheumatol Rep; 2019 Jun; 21(7):37. PubMed ID: 31197599
[TBL] [Abstract][Full Text] [Related]
16. The Early Phases of Ankylosing Spondylitis: Emerging Insights From Clinical and Basic Science.
Watad A; Bridgewood C; Russell T; Marzo-Ortega H; Cuthbert R; McGonagle D
Front Immunol; 2018; 9():2668. PubMed ID: 30505307
[TBL] [Abstract][Full Text] [Related]
17. Effect of enthesitis on 1505 Brazilian patients with spondyloarthritis.
Carneiro S; Bortoluzzo A; Gonçalves C; Silva JA; Ximenes AC; Bértolo M; Ribeiro SL; Keiserman M; Skare T; Menin R; Azevedo V; Vieira W; Albuquerque E; Bianchi W; Bonfiglioli R; Campanholo C; Carvalho HM; Costa Id; Duarte A; Kohem C; Leite N; Lima SA; Meirelles ES; Pereira IA; Pinheiro MM; Polito E; Resende GG; Rocha FA; Santiago MB; Sauma Mde F; Valim V; Sampaio-Barros PD
J Rheumatol; 2013 Oct; 40(10):1719-25. PubMed ID: 23858049
[TBL] [Abstract][Full Text] [Related]
18. Psoriatic spondylitis or ankylosing spondylitis with psoriasis: same or different?
Chandran V
Curr Opin Rheumatol; 2019 Jul; 31(4):329-334. PubMed ID: 31135567
[TBL] [Abstract][Full Text] [Related]
19. Mechanistic rationales for targeting interleukin-17A in spondyloarthritis.
Raychaudhuri SP; Raychaudhuri SK
Arthritis Res Ther; 2017 Mar; 19(1):51. PubMed ID: 28270233
[TBL] [Abstract][Full Text] [Related]
20. Evidence that tissue resident human enthesis γδT-cells can produce IL-17A independently of IL-23R transcript expression.
Cuthbert RJ; Watad A; Fragkakis EM; Dunsmuir R; Loughenbury P; Khan A; Millner PA; Davison A; Marzo-Ortega H; Newton D; Bridgewood C; McGonagle DG
Ann Rheum Dis; 2019 Nov; 78(11):1559-1565. PubMed ID: 31530557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
